HIGH

Duloxetine Capsules Recalled Due to High N-nitroso Impurity

Towa Pharmaceutical Europe recalled 1,856 bottles of Duloxetine delayed-release capsules on July 25, 2025. The recall follows the discovery of N-nitroso-duloxetine impurity exceeding FDA limits. Consumers should stop using the product immediately and seek guidance.

Quick Facts at a Glance

Recall Date
July 25, 2025
Hazard Level
HIGH
Brands
DULOXETINE, Quallent Pharmaceuticals Health, LLC
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
2 states
At-Risk Groups
GENERAL

Hazard Information

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Breckenridge Pharmaceutical, Inc. or your healthcare provider for guidance. Notification method: Letter

Product Details

The recall involves Duloxetine Delayed-Release Capsules, USP, 60 mg, with 1,000 capsules per bottle. The product, NDC 82009-032-10, was manufactured in Spain and distributed in New Jersey, Arizona, and Indiana.

The Hazard

The recall stems from CGMP deviations, specifically the presence of N-nitroso-duloxetine impurity above FDA recommended interim limits. This impurity poses potential health risks.

Reported Incidents

As of now, there are no reported incidents or injuries associated with this recall. The recall is classified as Class II.

What to Do

Stop using the product immediately. Consumers should contact Breckenridge Pharmaceutical, Inc. or their healthcare provider for further guidance.

Contact Information

For more information, visit the FDA recall notice at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0580-2025.

Key Facts

  • Recall date: July 25, 2025
  • Quantity recalled: 1,856 bottles
  • Manufactured by Towa Pharmaceutical Europe, S.L.
  • Distributed in NJ, AZ, IN
  • Class II recall due to safety risk

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeDuloxetine Delayed-Release Capsules
Sold At
Multiple Retailers

Product Details

Model Numbers
Lot 240539C
Exp 1/31/2027
UPC Codes
82009-029
82009-030
82009-032
+6 more
Affected States
NJ, AZ
Report Date
August 20, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

HIGH

Acuity Specialty Products Recalls Hand Sanitizer Due to Methanol Risk

Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.

Acuity Specialty Products
cGMP deviations:
Read more
HIGH

AFCO Hand Sanitizer Recalled Due to Methanol Risk

AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.

AFCO
cGMP deviations:
Read more